Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of NT 201 in the Unilateral Treatment of Essential Tremor of the Upper Limb
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2017
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- Sponsors Merz Pharmaceuticals GmbH
- 08 Jun 2017 Results assessing kinematics-guided inco/A therapypresented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 27 Sep 2016 Status changed from active, no longer recruiting to completed.
- 21 Jun 2016 Status changed from recruiting to active, no longer recruiting.